The IL-6/STAT3 signaling pathway has been proposed as a major linking mechanism between the inflammatory tumor microenvironment and pancreatic cancer [43, 44], which may promote the initiation and progression of tumors by regulating oncogenes [45] and epigenetic modifications of tumor suppressor genes [46, 47]. The gene discussed is IL6; the disease is familial pancreatic carcinoma.